Sign In
Buy AYTU
$2.09
-0.0100 (-0.476%)
At Close: Jun 03, 2026
Best Penny Stocks? 4 Hot Stocks With News This Week
11:55am, Thursday, 28'th Sep 2023
What do you consider the best penny stocks? Are they the ones exploding higher within a single session?
Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript
07:01pm, Wednesday, 27'th Sep 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q4 2023 Earnings Call Transcript September 27, 2023 4:30 PM ET Company Participants Robert Blum - IR Josh Disbrow - CEO Mark Oki - CFO Conference Call Participants
Q4 2023 net revenue of $30.7 million; Adjusted EBITDA of $7.7 million Record Q4 2023 total prescriptions increased 32% compared to Q4 2022 Rx Segment net revenue of $23.3 million and Adjusted EBITDA o
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
08:25pm, Thursday, 21'st Sep 2023
ENGLEWOOD, CO / ACCESSWIRE / September 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financ
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
08:00am, Wednesday, 13'th Sep 2023
ENGLEWOOD, CO / ACCESSWIRE / September 13, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced th
Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript
09:57pm, Thursday, 11'th May 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q3 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - Chief Executive Officer Mark Oki - Chief
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
04:30pm, Thursday, 04'th May 2023
ENGLEWOOD, CO / ACCESSWIRE / May 4, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescri
Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript
09:35pm, Tuesday, 21'st Feb 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q2 2023 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - Chief Executive Officer Mark Oki - C
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023
03:00pm, Tuesday, 21'st Feb 2023
ENGLEWOOD, CO / ACCESSWIRE / February 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused p
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023
08:00am, Tuesday, 07'th Feb 2023
ENGLEWOOD, CO / ACCESSWIRE / February 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused pr
Aytu BioPharma to Present at Lytham Partners Investor Select Conference on January 31
08:00am, Tuesday, 24'th Jan 2023
ENGLEWOOD, CO / ACCESSWIRE / January 24, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused pr
4 Short Squeeze Penny Stocks To Watch In January 2023; Time To Buy?
07:21pm, Friday, 13'th Jan 2023
Short squeeze penny stocks to watch this month. The post 4 Short Squeeze Penny Stocks To Watch In January 2023; Time To Buy?
Aytu BioPharma, Inc. (AYTU) Q1 2023 Earnings Call Transcript
06:58pm, Monday, 14'th Nov 2022
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q1 2023 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - CEO Mark Oki - CFO Conference Call P
Aytu BioPharma, Inc. (AYTU) CEO Josh Disbrow on Q4 2022 Results - Earnings Call Transcript
10:08pm, Tuesday, 27'th Sep 2022
Start Time: 16:30 January 1, 0000 5:12 PM ET Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q4 2022 Earnings Conference Call September 27, 2022, 16:30 PM ET Company Participants Josh Disbrow - Chairman and CEO M
Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022
08:00am, Tuesday, 20'th Sep 2022
ENGLEWOOD, CO / ACCESSWIRE / September 20, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rar
